|
RAB11A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.383900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438320E-03 |
| Normal-vs-Stage2 |
9.600100E-03 |
| Normal-vs-Stage3 |
1.136330E-02 |
| Normal-vs-Stage4 |
3.942500E-02 |
| Stage1-vs-Stage2 |
9.939000E-01 |
| Stage1-vs-Stage3 |
7.670200E-01 |
| Stage1-vs-Stage4 |
8.681000E-01 |
| Stage2-vs-Stage3 |
8.041200E-01 |
| Stage2-vs-Stage4 |
8.560000E-01 |
| Stage3-vs-Stage4 |
9.771600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.163030E-03 |
| Normal-vs-AfricanAmerican |
9.336200E-03 |
| Normal-vs-Asian |
1.871370E-01 |
| Caucasian-vs-AfricanAmerican |
5.759800E-01 |
| Caucasian-vs-Asian |
7.532400E-01 |
| AfricanAmerican-vs-Asian |
9.044600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54649999999368E-05 |
| Normal-vs-Female |
3.506600E-01 |
| Male-vs-Female |
4.374300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.454500E-02 |
| Normal-vs-Extreme_Weight |
4.40090000000115E-05 |
| Normal-vs-Obese |
4.095300E-03 |
| Normal-vs-Extreme_Obese |
3.780200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.341360E-01 |
| Normal_Weight-vs-Obese |
6.377400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.433200E-01 |
| Extreme_Weight-vs-Obese |
2.762200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.037400E-01 |
| Obese-vs-Extreme_Obese |
6.982200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.027500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.502600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.418140E-03 |
| Normal-vs-Age(81-100Yrs) |
1.384250E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.500600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.642400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.135400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.224400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.598350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.144800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.044240E-04 |
| Normal-VS-Type2 PRCC |
1.557530E-04 |
| Normal-VS-KIRP CIMP |
2.018000E-01 |
| Normal-VS-Unclassified PRCC |
3.777800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.747400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.136800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.950000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.331000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.780800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.628400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97089999998123E-06 |
| Normal-vs-N1 |
1.893960E-02 |
| Normal-vs-N2 |
1.389960E-01 |
| N0-vs-N1 |
4.536400E-02 |
| N0-vs-N2 |
6.795000E-01 |
| N1-vs-N2 |
6.284400E-01 |
|
|
